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Background: Tensin3 is an intracellular cytoskeleton-regulating protein, the loss of which is associated with
increased cell motility, as has been observed in some human cancers. A novel chromosomal translocation, t(2;7)
(p13;p12), present in a patient with a complex syndromic phenotype, directly involves Tensin3 (TNS3) and EXOC6B
genes. This translocation could impair the expression of Tensin3 and ExoC6B proteins, and potentially produce two
novel fusion transcripts. In the present study, we have investigated the expression and phenotypic features of these
potential products in cultured cells from the proband.
Methods: Skin fibroblasts isolated from the proband as well as an age-matched control were grown in cell culture.
Cells were used for quantitative RT-PCR, western blot and immunofluorescent confocal microscopy, which
determined Tensin3 gene and protein expression. Phase-contrast and confocal microscopy additionally revealed
cellular phenotype differences. A scratch wound assay monitored by live cell imaging measured cellular migration
rates.
Results: The levels of Tensin3 at both mRNA and protein levels were lower in proband cells versus control
fibroblasts. Proband cells displayed broader and shorter morphologies versus control fibroblasts, and
immunofluorescent staining revealed additional Tensin3 expression along cytoskeletal filaments and the cell
periphery only in control fibroblasts. In addition, proband fibroblasts showed a significantly higher migration rate
than control cells over 24 h.
Conclusions: The phenotypic changes observed in proband cells may arise from TNS3 haploinsufficiency, causing
partial loss of full-length Tensin3 protein. These results further expose a role for Tensin3 in cytoskeletal organisation
and cell motility and may also help to explain the syndromic features observed in the patient.
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The Tensins are a family of intracellular proteins, in-
cluding Tensin1, -2, -3 and −4 (cten), that appear cap-
able of linking the cytoskeleton to the cytoplasmic tails
of some transmembrane receptors, including β integrins
[1] and receptor tyrosine kinases [2,3]. Tensins are com-
posed of a characteristic set of domains that are involved
in discrete protein-protein interactions. The N terminal
is believed to bind F-actin whilst the C-terminal houses* Correspondence: sassan.hafizi@port.ac.uk
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reproduction in any medium, provided the ora tandem pairing of SH2 and PTB domains, which are
binding interfaces for several interaction partners includ-
ing FAK [4], p130Cas [3] and the tumour suppressor
DLC-1 [5]. Through these domain-mediated interac-
tions, the Tensins are believed to regulate cytoskeletal
dynamics and thereby related processes such as cell
shape, process formation, motility and apoptosis [6].
Therefore, any possible aberration that results in an al-
tered functionality or a complete or partial loss of the
Tensin protein, may feature in certain pathologies. This
has been shown to be the case in several cancers, where
Tensin genes show aberrant expression, with Tensin2
and Tensin3 [7,8] being down-regulated whilst Tensin4Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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explanation for these conflicting observations is that
Tensin4, which is a shorter Tensin variant and lacks the
N-terminal actin-binding domains, displaces the longer
Tensins [11]. This impairs the tethering of the actin fila-
ments to the plasma membrane and consequently alters
the cytoskeletal makeup of the cell, resulting in loss of cell
shape and increased cell motility. Such a phenomenon
may therefore underlie the metastatic potential of malig-
nant cancer cells.
We recently identified a unique genetic abnormality in-
volving Tensin3 in a patient who possessed a novel karyo-
type, resulting from a reciprocal balanced chromosomal
translocation, t(2;7)(p13;p12) [12]. The proband as an in-
fant presented with an underdeveloped left kidney and
right kidney dysfunction, as well as neutropenia and devel-
opmental problems. The proband’s karyotype featured a
fusion of chromosomes 2 (contains the EXOC6B gene)
and 7 (contains the TNS3 gene), yielding two possible fu-
sion sequences. The EXOC6B-TNS3 sequence contains
exon 1 of the EXOC6B gene and the last 15 exons of the
TNS3 gene, whilst the TNS3-EXOC6B sequence contains
exons 1–15 of the TNS3 gene and the last 20 exons of the
EXOC6B gene. ExoC6B (also known as Sec15B, Sec15L2)
is an 80–95 kDa protein that is part of the exocyst multi-
protein complex, which is involved in the polarised exo-
cytosis process, and also important for other processes
such as actin-based membrane protrusion, cell migration,
cell communication, cell growth and cell polarity [13].
Therefore, given the normal functions of Tensin3 and
ExoC6B, the clinical features observed in the proband in
our initial study could have arisen as a result of either
haploinsufficiency of the TNS3 and EXOC6B genes and/or
expression of dysfunctional chimeric proteins. However, at
the time we did not investigate whether both fusion tran-
scripts could potentially give rise to translated protein
products due to lack of specific tools for studying either
protein.
We gained an initial insight into the molecular features
of this homozygous aberration by detecting a marked re-
duction in expression of Tensin1 in cultured fibroblasts
from the proband compared to control ones [12]. Never-
theless, the actual fate of the direct molecular targets of
such a cytogenetic perturbation, i.e. Tensin3 and ExoC6B,
has not been investigated. Therefore, in the present study,
we have continued our investigation on the proband’s
cells, and here report our findings on: (i) the state of
TNS3 gene and protein expression, (ii) the potential pres-
ence of Tensin3-ExoC6B fusion proteins and (iii) the ef-
fect of the altered cytogenetic profile on cell migration of
such cells. Our results indicate that partial loss of full-
length Tensin3 may be responsible for the phenotypic
alteration of the proband’s cells, as observed through en-
hanced cell migration.Methods
Cell culture
Skin fibroblasts were obtained from the original proband
and an age-matched healthy counterpart, as previously
described [12]. Written informed consent for participa-
tion in the study was obtained from the parents of the
proband. Furthermore, the use of the cells for this study
was in accordance with the regulations of the ethics
committee of the University of Portsmouth. Cells were
cultured in Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 20% foetal calf serum, 100 U/ml peni-
cillin, 100 μg/ml streptomycin and 2 mM L-glutamine
(Lonza, Slough, UK). Cells were maintained by incubation
at 37°C in a humidified atmosphere of 5% CO2 in air and
passaged sparingly once a week.
Real-time quantitative reverse transcription-PCR
(qRT-PCR)
Human TNS3 gene expression in the fibroblasts was
analysed by quantitative RT-PCR (qRT-PCR) using the
ABI PRISM 7700 Sequence Detection System (Applied
Biosystems, Warrington, UK). Different sets of fluores-
cent primers and probes for TNS3 and a housekeeping
gene (GAPDH) were used for multiplex real-time PCR
detection of expression (Integrated DNA Technologies,
Leuven, Belgium). Total RNA was first extracted from
the fibroblasts using a kit (Qiagen, Crawley, UK), and
subsequently reverse transcribed in a reaction mix
containing oligodT primers, dNTPs, RT buffer, RNase in-
hibitor and reverse transcriptase (Fermentas, St. Leon-Rot,
Germany). The resulting cDNA (5 μl) was then added
to a qPCR reaction mix containing TNS3 and GAPDH
primers and probes, and qPCR polymerase master mix
(Maxima, Fermentas) to a final volume of 20 μl. The
cycling conditions were as described previously [8].
Each measurement was performed in triplicate wells
per reaction. The relative standard curve method of
quantitation was employed, using a standard curve of
TNS3 expression in cDNA from the human glioma cell
line SNB-19.
SDS-PAGE and western blot
Fibroblasts at near confluence in 6-well tissue culture
plates were rinsed in ice-cold phosphate-buffered saline
(PBS) and lysed in ice-cold lysis buffer composed of 1%
NP-40, 1% deoxycholate, 5 mM EDTA, 1 mM EGTA in
PBS, pH 7.4, supplemented with a protease inhibitor
cocktail (Calbiochem, Nottingham, UK). Cell lysates
were clarified by centrifugation at 20,800 rcf for 30 min
at 4°C, from which the supernatants were transferred to
new tubes. Total protein concentration was measured
with using a bicinchoninic acid (BCA) assay kit (Sigma,
Gillingham, UK). Equal protein amounts were loaded
onto 10% polyacrylamide gels for reducing SDS-PAGE,
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membrane. Membranes were blocked in 5% milk powder
in 25 mM Tris, 150 mM NaCl, 0.05% Tween-20, pH 8.0,
and then probed with primary antibodies at optimal di-
lutions. The anti-Tensin3 antibodies used included two
in-house rabbit polyclonal antibodies, raised against the
N- and C-terminal regions of Tensin3, the C-terminal
antibody having been characterised previously [8]. Also,
two new commercial anti-Tensin3 polyclonal antibodies
were used, raised in goat (Santa Cruz Biotechnology,
CA) and rabbit (Sigma). Furthermore, a goat polyclonal
ExoC6B antibody (Santa Cruz) was also tested on ly-
sates. Membranes were incubated with the primary anti-
body overnight at 4°C, then washed 3 times for 5 min in
wash buffer, 0.1 M Tris–HCl, 0.15 M NaCl, 0.05%
Tween 20, pH 8.0. They were then incubated for 1 h at
room temperature with secondary antibodies against the
relevant species primary antibody, conjugated to horse-
radish peroxidase (HRP) (Promega, Southampton, UK).
Further washes were followed by chemluminescent de-
velopment using an H2O2 and luminol-based reagent
mixture (HRP, Sigma).
Immunoprecipitation
For immunoprecipitation (IP) experiments, fibroblasts
were seeded into 10-cm tissue culture dishes and grown
to near confluence before lysis. Cells lysates were pre-
pared as for SDS-PAGE described above, and protein
concentration was determined so as to prepare samples
containing 500 µg total protein. Before IP, lysates were
initially pre-cleared by incubation with with 10 μl
protein A/G-agarose beads (Alpha Diagnostics, San
Antonio, TX) and mixed with gentle end-to-end rotation
for 1 h at 4°C. The beads were sedimented by quick cen-
trifugation, and the supernatant collected into separate
tubes to which 3 μg IP antibody was added; tubes were
rotated overnight at 4°C. The next day, the beads were
washed 3 times with ice-cold lysis buffer and once with
PBS. The proteins bound to beads were removed by
addition of 3x SDS loading buffer and brief boiling be-
fore being subjected to 10% SDS-PAGE and western blot
for Tensin3 detection, as described above.
Immunofluorescence staining and confocal microscopy
Fibroblasts were plated onto glass coverslips and allowed
to adhere overnight at 37°C, 5% CO2. The next day, cells
were rinsed with PBS and fixed with 4% formaldehyde
for 15 min, and permeabilised with 0.2% Triton X-100
for 10 min. For staining, cells were first blocked for 1 h
with 10% horse serum in PBS and then incubated with the
primary antibody (rabbit anti-Tensin3 in 1.5% serum) for
2 h at room temperature. Cells were washed three times
with PBS and then incubated with donkey anti-rabbit sec-
ondary antibodies conjugated to Alexa FluorW 647, at1:1000 dilution in 3% serum for 1 h at room temperature.
The coverslips were washed three times with PBS and
mounted onto glass slides using an aqueous, non-
fluorescent mountant (Polysciences, Eppelheim, Germany).
The samples were analysed under a confocal laser-
scanning microscope (LSM710; Zeiss, Oberkochen,
Germany), using a Plan Apochromatic 63× DIC oil ob-
jective (NA1.4). Images were processed with the soft-
ware Zen2008 Light Edition (Zeiss). Specificity of the
staining was verified by lack of fluorescence in cells in-
cubated with secondary antibodies alone.
Furthermore, live cells in culture were also viewed under
phase contrast microscopy, and images were captured
using a CCD digital microscope camera (DP50, Olympus).
Scratch-wound assay and live cell imaging microscopy
Fibroblasts were seeded in equal numbers (1.5 × 104)
into wells of a 24-well tissue culture plate and left to ad-
here overnight at 37°C and 5% CO2 prior the experi-
ment. Cells were at 90% confluence the next day, at
which point they were pre-incubated for 1 h with the
live cell fluorescent dye Cell Tracker ™ Blue (Life Tech-
nologies, Paisley, UK). In each well, three straight, paral-
lel scratches were made across the diameter of the well
using a 0.58 mm orifice size pipette tip. From that point
on, filling of the wound by migrating cells was moni-
tored under a live cell (time-lapse) imaging system com-
prising a Zeiss Axiovert 200 M microscope (Carl Zeiss,
Welwyn Garden City, UK) fitted with an incubator
(37°C, 5% CO2, humid atmosphere). A 5x (air) objective
was used; fluorescent images were acquired using
Volocity software (v5.4; Perkin Elmer, Bucks, UK) such
that 3 points across separate wound sections in each
well were imaged every 1 h for 72 h to measure wound
closure. The images were collated and movie sequences
generated. Image analysis of cell movement was carried
out using the free image processing program ImageJ
(http://rsb.info.nih.gov/ij/). Experiments were performed
in triplicate.
Statistical analyses
The levels of Tensin3 mRNA, the rates of cell migration
and proliferation at specific time points, and cell width
in control vs proband fibroblasts were compared by un-
paired t test. A P < 0.05 was considered statistically
significant.
Results
Quantification of normal Tensin3 mRNA expression in
proband and control fibroblasts
The levels of TNS3 gene expression were quantitatively
determined by real time qRT-PCR of RNA from proband
and control fibroblasts under both serum-containing
and serum-free conditions (Figure 1). In both conditions,
Ludwig et al. BMC Medical Genetics 2013, 14:65 Page 4 of 10
http://www.biomedcentral.com/1471-2350/14/65the Tensin3 mRNA expression level in proband fib-
roblasts was 20-30% lower than in control cells, al-
though the difference was statistically significant only
in full growth medium conditions. This suggests that
the chimeric mRNAs in the proband cells are less
stable and at least partially degraded, as compared to
the wildtype mRNAs for each gene in the control cells.
Full length Tensin3 protein expression is lower in
proband cells
In the proband’s cells, the potential existed for expres-
sion of Tensin3-ExoC6B or ExoC6B-Tensin3 chimeric
proteins, should their transcripts have been translated.
Table 1 outlines the molecular compositions of all four
possible protein products in the proband’s cells, also
illustrated schematically in Figure 2A. The Tensin3-
ExoC6B fusion protein would be composed of the first
340 amino acids of Tensin3 protein and the remaining
42 amino acids would be encoded by out-of-frame co-
dons arising from the fusion with the EXOC6B se-
quence. This would give rise to a predicted molecular
weight of 43 kDa on SDS-PAGE (Sequence Analysis pro-
gram, Informagen, USA). The ExoC6B-Tensin3 fusion
would be composed of the first 37 amino acids of
ExoC6B and a remaining stretch of 42 amino acids with
no identity, due a frameshift being introduced at the
breakpoint junction. This would give rise to a predicted
molecular weight of 9 kDa on SDS-PAGE.
We carried out western blots to determine the expres-
sion level of endogenous Tensin3 protein in the proband’s
fibroblasts versus those of an age-matched control. For
this, we used several different antibodies against human
Tensin3, including an in-house rabbit polyclonal that we
have verified before [8], as well as commercial rabbit and
goat polyclonal antibodies. To verify antibody specificity,
equal amounts of protein for each sample were run onFigure 1 Expression of Tensin3 mRNA expression in proband
and control fibroblasts. qRT-PCR was performed on RNA from cells
maintained under both full growth medium (first pair of bars) as
well as serum-free medium (SFM; second pair of bars). Results are
presented as % ± SD expression normalised to housekeeping gene
expression (ng TNS3/ng GAPDH). *P < 0.05 vs. control fibroblasts
under full growth medium conditions; n = 3.SDS-PAGE together with lysates from HEK293 cells stably
expressing recombinant human Tensin3, as described
previously [8]. The specificities of the antibodies varied,
although in all western blots, a band was observed for
Tensin3 at the expected molecular weight of around
170 kDa (Figure 2B, C), the same as for the Tensin3–
transfected control sample (Figure 2C). In all cases, the
Tensin3 immunoreactivity was significantly lower in
the proband’s cell extracts as compared to those of the
age-matched control cells. The most specific antibody
was the commercial rabbit polyclonal, which showed a
single clear band of the expected size for Tensin3, as
well as a single non-specific band at around 50 kDa
(Figure 2C). From this blot, densitometric analysis was
used to measure the intensity of the Tensin3 band as
normalised against the non-specific 50-kDa band for
each sample. The normalised intensity values (100% for
the 50-kDa band) were 25.44% (proband) and 42.31%
(control), showing that the proband cells contain
roughly half of the full length Tensin3 protein that con-
trol fibroblasts do.
For detecting the putative Tensin3-ExoC6B fusion pro-
tein, both the in-house and commercial rabbit anti-
Tensin3 antibodies were raised against sequences in the
N-terminal of Tensin3, and so would be expected to de-
tect such a chimeric protein if it existed. However, no
clear unique band in the region of 43 kDa was detected
in the proband fibroblast extract using these antibodies
(Figure 2B, C). In addition, we performed immunopre-
cipitation experiments on the proband cell extracts using
an in-house N-terminal antibody to pull down both full-
length Tensin3 as well any potential chimeric protein.
However, neither full-length Tensin3 nor a specific
43-kDa band representing the Tensin3-ExoC6B fusion
protein were detected in western blots of the immuno-
precipitated complexes, indicating that the antibody
failed to pull down either form of Tensin3 (not shown).
Furthermore, a commercial antibody against ExoC6B
was also tested on cell lysates, where a 94-kDa band for
the full length protein was expected to be detected.
However, no such band was visible for either sample
(data not shown).
Distinct morphology and immunofluorescence
localisation of Tensin3 in proband fibroblasts
When viewed by phase contrast microscopy, proband fi-
broblasts exhibited a distinct morphology as compared
to control cells. Proband cells appeared shorter and
broader in cell body dimensions, whilst control fibro-
blasts appeared longer and thinner (Figure 3A). We
quantified the width of the cell bodies within each cul-
ture (ImageJ) and determined the proband cells to be
significantly wider than control fibroblasts (mean ± SEM
width (arbitrary units) of proband cells 107.23 ± 3.62,
Table 1 Molecular compositions of protein products of
potential transcripts in the proband cells
Protein (GenBank ID) Amino acid
composition
Approximate
predicted molecular
weight (kDa)
Tensin3 (NP_073585) 1445 aa 155
ExoC6B (NP_056004) 811 aa 94
Tensin3-ExoC6B
chimera
382 aa (aa 1–340 of
Tensin3; aa 341–382
unique)
43
ExoC6B-Tensin3
chimera
79 aa (aa 1–37 of
ExoC6B; aa 38–79
unique)
9
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munofluorescent staining and confocal microscopic ana-
lysis were carried out in proband and control fibroblasts
to detect Tensin3 and ExoC6B expression. Using two
separate in-house antibodies, staining for Tensin3 was ob-
served in both types of cells at similar intensities, mostly
exhibiting a punctate pattern of expression throughout the
cytoplasm (Figure 3B), as has previously been reported by
us for Tensin2 [14]. However, in control fibroblasts alone,
Tensin3 staining was also apparent along cytoskeletal
filaments and the cell periphery, whereas this profile
was absent in proband cells. Cells were also immuno-
stained for ExoC6B, with both cell types exhibiting a
weak punctuate and membrane-associated fluorescence
pattern in equal measure. All immunofluorescent stain-
ing was verified by omission of primary antibody in
negative control samples, where negligible fluorescence
was observed.
Proband fibroblasts exhibit a greater migration rate as
compared to control cells
The migration rates of proband and control fibroblasts
were measured using a scratch wound assay, with cells
being monitored in real time under live cell imaging
(Figure 4). Additional files 1 and 2 contain video se-
quences showing scratch wound filling by the two cell
cultures over 72 h, whilst Figure 4A shows snapshots at
0, 36 and 72 h after post-wound image capture began.
Quantification of the results showed that proband fibro-
blasts migrated at a higher rate than control cells over
the entire 72 h (Figure 4B). Proband fibroblasts first
began to migrate out from the periphery of the wound
at 12 h after its creation, versus 18 h for control cells.
Proband cells showed consistently greater coverage of
the wound area than control cells between 12 h and
60 h, with complete closure of the wound being achieved
by 60 h for proband cells versus 72 h for control cells.
When considering the rates of migration (distance cov-
ered per unit time), proband cells showed statisticallysignificantly higher migration rates than control cells
within the initial 24-h period (P < 0.001; n = 3), after-
wards being caught up by control cells due to nearing
confluence in the wells. Furthermore, cell proliferation
played no part in the observed cell migration differences,
as the two cell cultures exhibited similar proliferation
rates with no significant differences (Additional file 3).
Discussion
In the present study, we have built upon the initial discov-
ery of a unique cytogenetic abnormality in a young patient
that constituted a reciprocal chromosomal translocation, t
(2;7) (p13;p12), involving the genes TNS3 and EXOC6B
[12]. However, at that time no adequate tools were avail-
able to study the status of the proteins that may be af-
fected. Therefore, in the present study, we have utilised a
set of new and unique tools specific for Tensin3, to carry
out a molecular and functional characterisation of cells
harvested from the patient. The major finding from our
study is that wildtype Tensin3 expression is impaired in
the patient, the functional significance of which is trans-
lated to a greater migratory capacity in patient’s cells.
These data tie in well with our previous observations
and ensuing hypothesis that Tensin3 normally functions
as an anti-migratory molecule, which is supported by
our previous observation of a loss of Tensin3 in human
renal cell carcinoma amongst other cancers [8]. Fur-
thermore, the important functional role of Tensin3 in
the kidney is underscored by the fact that the patient
under study showed impaired kidney development and
function.
Our qRT-PCR analysis revealed a lower expression of
normal Tensin3 mRNA transcripts in proband cells as
compared to control cells. This was significant however
only in full growth medium, possibly due to the fact that
Tensin3 expression was much lower under starvation con-
ditions to barely detectable levels to be able to discern a
clear difference (not shown). Provided that correct spli-
cing of pre-mRNA occurred in all transcript forms, the
qRT-PCR primers and probes we used would recognise
both wildtype and chimeric EXOC6B-TNS3 transcripts.
These quantitative expression results therefore show
that there is an imbalance in the levels of transcripts
containing the Tensin3 sequences analysed. This indi-
cates that the cellular quality control mechanisms have
removed at least a proportion of the aberrant tran-
scripts e.g. through nonsense-mediated mRNA decay.
The chimeric and EXOC6B transcripts were not mea-
sured in this study due to lack of specific primers/
probes.
At the protein level, we found a lower basal expression
of endogenous wildtype Tensin3 in the proband cells.
However, we observed no concomitant presence of ei-
ther of the two putative chimeric fusion proteins. In
Figure 2 Characterisation of Tensin3 protein expression in proband and control fibroblasts. A: Schematic representation of wildtype
Tensin3 and ExoC6B proteins, as well as putative chimeric proteins that could arise from unimpeded expression of the two new open reading
frames created from the chromosomal translocation. Amino acid number is shown at the N and C terminal ends and identified protein domains
are indicated in boxes within each protein. In the chimeric proteins, jagged lines indicate the fusion point of the wildtype sequence with that of
a novel open reading frame. B, C: Western blots of Tensin3 expression in proband and control fibroblasts. Equal amounts of total protein from
each cell extract were run on SDS-PAGE. Blots show immunoreactivity of two different anti-Tensin3 antibodies recognising the Tensin3 N-terminal,
Santa Cruz (B) and Sigma (C). The Tensin3 band is indicated by an arrow. In blot c, lane 1 contains HEK 293 cell extract expressing recombinant human
Tensin3 as a positive control. All blots are representatives of three separate western blots performed.
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bodies that would have detected the Tensin3-ExoC6B
chimera as a 43-kDa band on western blots. A possible
explanation for the absence of the chimeric protein could
be that the fusion DNA sequence was not transcribed. Al-
ternatively, both transcription and translation may occur
but may have been followed rapidly by post-translational
processing and degradation of the protein, driven by the
cell’s ubiquitin-proteasome complex [15]. However, the
most likely event is, as premature translation-termination
codons (PTCs) are produced in the case of both fusion se-
quences, the selective recognition and degradation of theaberrant transcript prior to translation, occurring through
the nonsense-mediated mRNA decay (NMD) pathway
[16]. The occurrence of PTCs upstream of a fixed point in
the penultimate exon of the normal gene sequence enables
them to be distinguished from bona fide termination
codons. The NMD pathway then degrades these tran-
scripts through endo- or exonucleolytic cleavage, as part
of a ubiquitous mechanism to prevent cellular production
of potentially toxic truncated proteins, which is moreover
linked with the proteasome system [15].
Microscopic analyses of the proband and control cells
revealed subtle differences between them in terms of
Figure 3 Immunofluorescent confocal microscopic analysis of Tensin3 and ExoC6B in proband and control fibroblasts. A: Live cells were
imaged using phase contrast microscopy; scale bar represents 63 μm. B: Cells were fixed, permeabilised and stained using specific antibodies:
anti-Tensin3 in-house antibody no. 1 (recognising a C-terminal sequence; green fluorescence; top row), anti-Tensin3 in-house antibody no. 2
(recognising an internal sequence; green fluorescence; middle row), and a commercial goat anti-ExoC6B antibody (red fluorescence; bottom row).
The secondary antibody was coupled to Alexa Fluor® 647 fluorochrome. Stained cells were imaged under a confocal microscope as described.
Arrows indicate Tensin3 immunoreactivity in actin filamentous structures. Negative control images were also taken of cells not incubated with
primary antibody (third image each row). Scale bar represents 20 μm.
Ludwig et al. BMC Medical Genetics 2013, 14:65 Page 7 of 10
http://www.biomedcentral.com/1471-2350/14/65their morphologies and the distribution of intracellular
Tensin3 expression. Proband fibroblasts cells exhibited
significantly broader and shorter cell bodies than control
cells, which could arise from a lesser tension due to re-
duced contacts between the cytoskeleton and the cell
periphery. To probe this, it will be worthwhile as a
follow-up to analyse molecular markers of cell shape
changes, including focal adhesion and mesenchymal
proteins. Furthermore, immunofluorescent staining for
Tensin3 showed a punctate expression pattern within
both cell types with equal intensities and distributions.These could display fibrillar adhesions, which is where
Tensin3 was recently observed to mainly localise to in
human skin fibroblasts, colocalising with α5β1 integrin
within those structures [17]. However, an additional
clear and well-defined Tensin3 staining along cytoskel-
etal filaments and the cell periphery was present only in
the control cells. Therefore, a lower amount of full-
length Tensin3 protein appears to exist in the proband
cells, as a sufficient expression level allows a subset of
wildtype Tensin3 to closely interact with actin filaments.
This feature would be plausible as the larger Tensin
Figure 4 Cell migration assay of proband and control fibroblasts. Live cell imaging was used to monitor movement of cells into an open
scratch wound over 72 h, with images being captured every 1 h. A: Image snapshots were captured at 0, 36 and 72 h after post-wound image
capture began. Live cells have been stained with Cell Tracker™ Blue fluorescent dye, and a white line marks the edge of the scratch wound. Scale
bar represents 200 μm. B: Quantitative representation of distance covered by cells within the scratch wound over the 72-h analysis period.
Results are expressed as mean ± SEM % distance covered by the cells per unit time (h), with 100% representing complete filling of the wound;
n = 3 scratches for each cell type.
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mains in their N terminal regions, which the shorter
Tensin4 (cten) lacks [6].
Another phenotypic difference we observed between
proband and control fibroblasts was the greater migra-
tion rate of proband cells. We have previously shown
that Tensin3 overexpression in HEK 293 cells inhibits
cell migration, and this correlates with downregulation
of Tensins in human kidney cancer [8]. Furthermore,
EGF treatment of cancer cells leads to downregulation
of Tensin3 and concomitant upregulation of cten,correlating with enhanced cell migration [11]. These re-
sults therefore indicate that Tensin3 normally functions
as a cell migration-inhibitory molecule. At least in can-
cer cells, Tensin3 appears to control cell migration by
signalling through the deleted in liver cancer-1 (DLC-1)
protein, which is a Rho-specific GTPase activating pro-
tein (Rho-GAP) [5]. In this pathway, Tensin3 activates
the Rho-GAP activity of DLC-1, enabling it to inhibit
RhoA through hydrolysis of its bound GTP, and conse-
quently Rho-kinase (ROCK), the immediate down-
stream effector of RhoA [18]. This results in reduced cell
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dissociation of focal adhesions. However, it must also be
stated that Tensin3 has also been shown to promote
cancer cell migration and growth, in particular through
Src-dependent tyrosine phosphorylation of its SH2 do-
main and subsequent specific interactions [5]. This feature
however appears to be an outcome in cancer cells, where
DLC1 is downregulated and Src oncogene activity is high.
Therefore, in the skin fibroblasts that we have studied
here, where the opposite is true, normal expression of
wildtype Tensin3 appears have the expected effect.
As gain-of–function expression of putative chimeric
proteins is unlikely, we therefore propose that Tensin3
haploinsufficiency is a pathogenetic mechanism for the
cellular phenotypes that we have observed. These pheno-
typic changes may play a role in the syndromic status of
the patient reported in the original study, which included
impaired kidney development and function, recurrent pul-
monary infections, severe gastroesophageal reflux, bone
marrow hypoplasia, and retarded development [12]. Al-
though speculation is limited, Tensin3 impairment in
humans may at least contribute to a kidney phenotype, as
Tensin3 is normally expressed in the human kidney cor-
tex, being mainly localised to proximal tubular epithelial
cells [8]. Moreover, genetic impairment of Tensin3 may
have a wider consequence than simply affecting Tensin3
and ExoC6B proteins only, as we previously showed that
the cellular distribution of Tensin1 is also reduced in the
Tensin3-haploinsufficient fibroblasts of the patient [12].
Therefore, it may be that the concurrent loss of more than
one Tensin family member is the true driving force behind
the phenotypic alterations observed in the patient. Inter-
estingly, a separate study has identified a different bal-
anced translocation involving the TNS3 gene, in this case
also affecting the FGFR1 gene, with the patient displaying
hypogonadotropic hypogonadism and cleft lip and pal-
ate [19]. However, no unique phenotypic abnormalities
were observed in that patient that could distinguish
them from those seen in Kallmann Syndrome arising
from FGFR1 point mutations. Therefore, although het-
erozygous Tensin3 impairment did not seem to have a
noticeable effect in that case, the possibility could not
be excluded that the predicted fusion proteins were
compensating through functioning as the normal pro-
tein. It is noteworthy that more than one type of trans-
location involving chromosome position 7p12.3 has
been detected, indicating that this location is more sus-
ceptible to breakage than most other locations [20].
Furthermore, Tensin3 knockout mice display growth re-
tardation and postnatal lethality, as well as incomplete
development of the lung, small intestine and bone, al-
though heterozygous mice were phenotypically normal
[21]. Therefore, Tensin3 appears to play a role in the
development and function of several organs of the body,through maintenance of cell and tissue architecture. In
contrast to Tensin3, the precise function and role of the
ExoC6B protein are barely characterised, partly due to a
lack of reliable and specific tools to study this molecule.
Therefore, the functional consequences of the chromo-
somal translocation effect due to changes in ExoC6B
protein remain to be investigated.
Conclusions
Tensin3 haploinsufficiency manifests itself in an altered
phenotype in the explanted cells of the patient, involving
reduced levels of wildtype Tensin3 protein as well as an
enhanced migration rate. This novel information high-
lights the consequences of Tensin3 impairment in hu-
man pathophysiology, as well as elucidating further the
role of Tensin3 in normal human physiology.
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